<?xml version="1.0" encoding="UTF-8"?>
<ref id="B96-antibiotics-10-00092">
 <label>96.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qiao</surname>
    <given-names>J.X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Ruel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Thibeault</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lâ€™Heureux</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Schumacher</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>Spronk</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Hiebert</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bouthillier</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lloyd</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Conformationally constrained orthoanilino diaryl ureas, discovery of 1-(2-(10-neopentylspiro[indoline-3,40-piperidine]-1-yl)phenyl)-3-(4-(trifluoro-methoxy) phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist</article-title>
  <source>J. Med. Chem.</source>
  <year>2013</year>
  <volume>56</volume>
  <fpage>9275</fpage>
  <lpage>9295</lpage>
  <pub-id pub-id-type="doi">10.1021/jm4013906</pub-id>
  <pub-id pub-id-type="pmid">24164581</pub-id>
 </element-citation>
</ref>
